Physicist César Hidalgo at the Massachusetts Institute of Technology has launched a series called “Cambridge Nights: Conversations About a Life in Science,” which is intended to allow scientists to open up about their lives, their work and their views of the world. Marc Vidal, HMS professor of genetics at Dana-Farber Cancer Institute, was one of the participants.
Researchers report their work with mice indicates the myelin sheath surrounding nerves lost to multiple sclerosis may be partially rejuvenated. Amy J. Wagers, HMS associate professor of stem cell & regenerative biology at Joslin Diabetes
Center, is one of the study authors.
Blend Therapeutics announced its launch as a Watertown biotechnology company that aims to focus on so-called “combination medicines.” Company founders include Robert Langer, HMS senior lecturer on surgery and David H. Koch Institute Professor at the Massachusetts Institute of Technology, and Omid Farokhzad, HMS associate professor of anesthesia at Brigham and Women’s Hospital.
Cambridge start-up NinePoint Medical Inc. has received clearance from the Food and Drug Administration to sell a new high-resolution optical imaging device that uses technology licensed from Massachusetts General Hospital.
Gary Tearney, HMS professor of pathology at Massachusetts General Hospital and Brett Bouma, HMS professor of dermatology at Massachusetts
General Hospital, invented the technology.
Ted Kaptchuk, HMS associate professor of medicine at Beth Israel Deaconess Medical Center, was recently a guest on NPR to discuss potential applications for the healing power of placebos.
St. Elizabeth’s Medical Center has signed an agreement with Dana-Farber Cancer Institute to provide cancer care to St. Elizabeth’s patients and give them access to experimental therapies.
Kevin Tabb, chief executive officer at Beth Israel Deaconess Medical Center, announced yesterday that chief operating officer Eric Buehrens has decided to step down from his position at the end of February.
An experimental herpes vaccine failed to protect young women from the disease in a new study. David Knipe, Higgins Professor of Microbiology and Immunobiology at HMS, is quoted.
The New England Journal of Medicine is the oldest continuously publishing medical journal in the world and is celebrating its 200th anniversary this year. Jeffrey Drazen, the Parker B. Francis Distinguished Professor of Medicine at Brigham and Women’s Hospital, is the current editor-in-chief.
